NCT03072043 2022-01-24Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid NeoplasmsH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Completed55 enrolled 15 charts